EBR – Morgans rates the stock as Speculative Buy
The target falls to $1.38 from $1.84 to reflect increased volatility and higher funding costs. The Speculative Buy rating is maintained.
Read More
Ebr Systems Inc
EBR Systems is driven to deliver superior treatment for millions of patients suffering from cardiac rhythm diseases by developing safe, clinically superior, cost-effective and reliable therapies using wireless cardiac stimulation.
Videos
Videos coming soon for Ebr Systems Inc.
News
